-
Decoding FDA's Proposed ACNU Rule and Unveiling Its Implications for the OTC Industry
23-24 January 2024
American Conference Institute
Advanced Legal, Regulatory & Compliance Forum on OTC Drugs
New York, New York
Speaking Engagements
-
Illuminating the Role of the FTC in Healthcare Advertising Enforcement
2 November 2023
Food and Drug Law Institute
Advertising & Promotion for Medical Products Conference
Washington, DC
Speaking Engagements
-
Emerging Dispute Trends: Telecoms, Tech and Pharma
25 August 2023
African Arbitration Association
10th East Africa International Conference
Zanzibar
Speaking Engagements
-
From Primary to Secondary use of Health Personal Data, from Open Data to Intellectual Property Investment Protection: is Privacy Opposed to Data Valuation?
31 May - 2 June 2023
International Bar Association
9th Annual IBA World Life Sciences Conference
Washington, DC
Speaking Engagements
-
Key Transactional, Legal & Regulatory Developments for Healthcare Investors
3 February 2022
Debevoise & Plimpton LLP
Webcast
Speaking Engagements
-
Key Transactional, Legal and Regulatory Developments for Life Sciences Companies and Their Investors
27 January 2022
Debevoise & Plimpton LLP
Webcast
Speaking Engagements
-
Comparative Approaches to AI Transparency: Lessons from Recent Regulatory Efforts
14 October 2021
U.S. Food and Drug Administration
FDA Workshop on Transparency of Artificial Intelligence/Machine Learning-enabled Medical Devices
Webcast
Speaking Engagements
-
Conducting an Internal Investigation
26 April 2021
Seton Hall University School of Law
Latin America Healthcare Compliance Certificate Program
Webcast
Speaking Engagements
-
Private Equity and Healthcare in Africa
21 April 2021
African Private Equity and Venture Capital Association
AVCA 2021 Annual Conference
Webcast
Speaking Engagements
-
Compliance Considerations and Mitigation Measures for Pharmaceutical and Medical Device Companies Operating in Russia
16 March 2021
Debevoise & Plimpton LLP
Life Sciences Roundtable
Webcast
Speaking Engagements
-
Over the Counter Drugs
26 February 2021
American Conference Institute
Advanced Legal, Regulatory and Compliance Forum
Webcast
Speaking Engagements
-
The Impact of the Biden Administration on Life Sciences and Consumer Product Companies and Investors
29 January 2021
Debevoise & Plimpton LLP
Webcast
Speaking Engagements
-
Telehealth and Telemedicine: How Technology is Changing Deals in the Healthcare Sector
21-24 September 2020
The Deal
The Deal Economy: Predictions and Perspectives
Webcast
Speaking Engagements
-
State Aid and Governmental Support During the Covid-19 Outbreak
12 June 2020
AIJA (Association Internationale des Jeunes Avocats – International Association of Young Lawyers)
Antitrust and Healthcare Webinar: Pharma Regulations and State Support in Times of COVID-19
Webinar
Speaking Engagements
-
FDA Regulation of OTC Drugs After the CARES Act: Opportunities for Innovation
13 May 2020
Debevoise & Plimpton LLP
Webinar
Speaking Engagements
-
Medical Devices and Cybersecurity and Privacy, Oh My!
7 May 2020
American Intellectual Property Law Association
Intersection of Medical Devices and Software
Webinar
Speaking Engagements
-
FDA’s Response to the Novel Coronavirus: What Life Sciences Companies and Investors Need to Know
9 April 2020
Debevoise & Plimpton LLP
Webinar
Speaking Engagements
-
Deep Dive Case Study Workshop - Healthcare
8 October 2019
EMPEA
EMPEA Sustainable Investing in Emerging Markets Summit
London, UK
Speaking Engagements
-
Antitrust Enforcement in the Pharmaceutical Industry
26 September 2019
District of Columbia Bar
DC Bar Antitrust and Consumer Law Institute
Washington, DC
Speaking Engagements
-
A Look at the Healthcare Industry
17 September 2019
International Financial Law Review
IFLR India M&A Forum
Mumbai, India
Speaking Engagements
-
Global Trends and Challenges in Healthcare M&A
16 September 2019
Debevoise & IDEX Legal
Networking and Discussions on Healthcare M&A
Mumbai, India
Speaking Engagements
-
CBD and Hemp: State Law Developments and Legal Status of Cosmetics
3-4 May 2019
Food and Drug Law Institute
FDLI's Annual Conference
Washington, DC
Speaking Engagements
-
Healthcare & Pharma Regulation through Antitrust Legislation
25 April 2019
American Bar Association
Healthcare & Pharma Regulation through Antitrust Legislation
Webinar
Speaking Engagements
-
The SEC/FDA Nexus: Best Practices for Publicly Traded Life Sciences Companies
20 February 2019
Practicing Law Institute
Practice Briefing
Speaking Engagements
-
Medical Device Post-Market Cybersecurity – Stakeholder Interactions and the Importance of Advancing Coordinated Vulnerability Disclosure
7 February 2019
Practicing Law Institute
Practice Briefing
Speaking Engagements
-
Recent Developments in Health Care & Pharmaceuticals in Antitrust
30 January 2019
American Bar Association
ABA Antitrust Section Q4 2018 Health Care & Pharmaceuticals
New York, New York
Speaking Engagements
-
Medical Device Cybersecurity
20 November 2018
Medical Device Innovation Consortium
MDIC Webinar
Webinar
Speaking Engagements
-
Health Claims and the Interrelationship Between FDA, the FTC and NAD
8 November 2018
New York City Bar Association
New York City Bar, Consumer Affairs Committee
New York, New York
Speaking Engagements
-
Working with the Active Board of Today
8 November 2018
ExL Events Inc
Vanguard Healthcare Forum
New York, New York
Speaking Engagements
-
Navigating the Healthcare Market in India
6 September 2018
IFLR
IFLR India M&A Forum
Mumbai, India
Speaking Engagements
-
Medical Device Cybersecurity: Coordinated Vulnerability Disclosure
5 September 2018
Medical Device Innovation Consortium
2018 Annual Public Forum 2018 MDIC Annual Public Forum
Washington, DC
Speaking Engagements
-
Dietary Supplements
18 June 2018
American Conference Institute & Council for Responsible Nutrition
ACI-CRN Dietary Supplements Conference
New York, New York
Speaking Engagements
-
The Impact of the U.S. Foreign Corrupt Practices Act in Europe and Beyond
14 November 2017
Seton Hall Law
Certificate in European Healthcare Compliance, Ethics and Regulation
Paris, France
Speaking Engagements
-
Hot Topics in Healthcare Transactions
3 November 2017
International Bar Association
IBA Asia Pacific Mergers and Acquisitions Conference 2017
Hong Kong
Speaking Engagements
-
Opportunities and Trends in Healthcare – How to Achieve Scalable Impact
17 October 2017
Emerging Market Private Equity Association
Sustainable Investing in Emerging Markets
London, UK
Speaking Engagements
-
How Companies Can Turn the Page and Move On After a Scandal: A Focus on Corporate Culture and Restoration of Confidence
27-28 July 2017
American Conference Institute
ACI’s 11th Advanced Forum on FCPA & Anti-Corruption in the Life Sciences Industry
New York, New York
Speaking Engagements
-
Health Care Issues in Emerging Markets
28 June 2017
Practising Law Institute
New York, New York
Speaking Engagements
-
To Europe & Beyond: The Impact of the U.S. Foreign Corrupt Practices Act
7 June 2017
Seton Hall Law and SciencesPo
European Healthcare Compliance, Ethics & Regulation
Paris, France
Speaking Engagements
-
A Finger on the Pulse – Investments in Healthcare
5 April 2017
African Private Equity and Venture Capital Association
AVCA Conference
Abidjan, Côte d’Ivoire
Speaking Engagements
-
Health Care M&A: Three Hot Topics
3 April 2017
Practising Law Institute
PLI One-Hour Briefing
New York, New York
Speaking Engagements
-
Emerging Markets Forum: Pharma and OTC Go-To-Market Strategies, Partnerships and Market Access
13-14 March 2017
Spotlight: Russia & the Eurasian Economic Union (EAEU)
Adam Smith Conferences
Berlin, Germany
Speaking Engagements
-
Hot Topics in Healthcare Transactions
1 March 2017
International Financial Law Review
IFLR Asia M&A Forum
Hong Kong
Speaking Engagements
-
Hot Topics in U.S. Healthcare Transactions
12 December 2016
Debevoise & Plimpton
Debevoise & Plimpton LLP, Hong Kong
Speaking Engagements
-
Recent Regulatory and Other Issues Relating to M&As in the U.S. Healthcare Industry
8 December 2016
Nishimura & Asahi
Nishimura & Asahi Seminar
Tokyo, Japan
Speaking Engagements
-
Recent Regulatory and Other Issues Relating to M&As in the U.S. Healthcare Industry
7 December 2016
Nishimura & Asahi
Nishimura & Asahi Seminar
Tokyo, Japan
Speaking Engagements
-
UK Bribery Act And The “Adequate Procedures Defense”
28 April 2016
American Conference Institute
FCPA and Anti-Corruption for the Life Sciences Industry
New York, New York
Speaking Engagements
-
Healthcare in the Department of Justice’s Crosshairs – It’s Not Just a Civil Matter Anymore
15 April2016
American Bar Association (ABA)
American Bar Association, Section Annual Conference
Chicago, Illinois
Speaking Engagements
-
Specialized Incident Response Blueprints: Retail, HealthCare and Financial Data Breaches
31 March 2016
Cybersecurity Docket
Incident Response Forum 2016
Washington, D.C.
Speaking Engagements
-
Ad Law: Hot Topics, Enforcement Trends & Substantiation Considerations for OTC, Device & Rx Products
12 May 2015
Galderma International
Galderma International In-House Counsel Conference
New York, New York
Speaking Engagements
-
Globalization: Facing Trademark and Trade Dress Litigation in a Generic Environment
28 April 2015
GlaxoSmithKline
GlaxoSmithKline In-House Counsel Conference
Philadelphia, Pennsylvania
Speaking Engagements
-
CIAs: What You Need to Consider
Eastern Standard Time
ACI
ACI’s 15th Advanced Forum on Fraud & Abuse in the Sales and Marketing of Medical Devices
Boston, Massachusetts
Speaking Engagements
-
Navigating the Global Marketplace
Eastern Standard Time
ACI
ACI’s 15th Advanced Forum on Fraud & Abuse in the Sales and Marketing of Medical Devices
Boston, Massachusetts
Speaking Engagements
-
Avoiding Legal Ethical Issues During a Government FCA or Anti-Kickback Investigation
24-25 February 2015
American Conference Institute (ACI)
ACI Conference on Ethics for Life Sciences Attorneys
Philadelphia, PA
Speaking Engagements